[Therapeutic strategy in thymomas]

Minerva Chir. 1997 Jun;52(6):777-82.
[Article in Italian]

Abstract

Between July 1989 to February 1994 eight patients with thymoma were operated in the First surgical Clinic of University of Catania; in seven the neoplasia was associated with myasthenia gravis, the severity of which was evaluated according to the Osserman's classification. The surgical treatment has been: total thymectomy in four patients, in two total and partial resection was carried out respectively, and in two a macrobiopsy was performed. The postoperative staging was carried out according to Masaoka. The neoadjuvant chemotherapy and postoperative radiation therapy have been analyzed. The authors concluded that a rigorous anatomo-surgical and histopathological classification is the best way for the right use of postoperative adjuvant therapies to reduce the incidence of local and distant recurrence of these tumors.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibiotics, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Cisplatin / therapeutic use
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myasthenia Gravis / complications
  • Postoperative Care
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Thymectomy
  • Thymoma / radiotherapy
  • Thymoma / surgery
  • Thymoma / therapy*
  • Thymus Neoplasms / radiotherapy
  • Thymus Neoplasms / surgery
  • Thymus Neoplasms / therapy*

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Alkylating
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin